Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001085146-25-004810
Filing Date
2025-08-11
Accepted
2025-08-11 16:49:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5192
  Complete submission text file 0001085146-25-004810.txt   7215
Mailing Address 711 HIGH STREET DES MOINES IA 50392-0300
Business Address 711 HIGH STREET DES MOINES IA 50392-0300 515-247-5111
PRINCIPAL GLOBAL INVESTORS (Filed by) CIK: 0000769734 (see all company filings)

EIN.: 421479618
Type: SCHEDULE 13G/A

Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Subject) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-88843 | Film No.: 251202688
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)